Completed OBSERVATIONAL NCT03283176

Hematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without Ribavirin

Changes in Hematologic Profile, Vitamin B12 and Folic Acid Level in Cirrhotic Patients Received Sofosbuvir and Daclatasvir With or Without Ribavirin

Sponsor: Assiut University

Conditions Chronic Hepatitis c Directly Acting Antivirals Liver Cirrhoses

Interventions Vitamin B12 and Folic Acid

Updated 8 times since 2017 Last updated: Oct 14, 2020 Started: Mar 1, 2018 Primary completion: Mar 1, 2019 Completion: Jan 14, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Chronic Hepatitis c and Directly Acting Antivirals and is currently completed. Assiut University leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

Status: Unknown Status → Completed

▶ Show 3 earlier versions

Oct 2019 — Nov 2020 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Apr 2018 — Oct 2019 [monthly]

Not Yet Recruiting

Phase: NA → None
Oct 2017 — Apr 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Asyut, Egypt